Efficacy and safety of low-dose valganciclovir for prevention of cytomegalovirus disease in renal transplant recipients: a single-center, retrospective analysis.
第一作者:
Steven,Gabardi
第一单位:
Department of Pharmacy Services, Brigham and Women's Hospital, Boston, MA 02115-6110, USA. sgabardi@partners.org
作者:
主题词
成年人(Adult);老年人(Aged);抗病毒药(Antiviral Agents);巨细胞病毒感染(Cytomegalovirus Infections);女(雌)性(Female);更昔洛韦(Ganciclovir);人类(Humans);免疫抑制剂(Immunosuppressive Agents);肾移植(Kidney Transplantation);男(雄)性(Male);中年人(Middle Aged);回顾性研究(Retrospective Studies);时间因素(Time Factors);治疗结果(Treatment Outcome)
DOI
10.1592/phco.24.14.1323.43152
PMID
15628830
发布时间
2022-04-08
- 浏览28

Pharmacotherapy
1323-30页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文